跳至主要内容
临床试验/ACTRN12609000796280
ACTRN12609000796280尚未招募2 期

A comparison of a vapocoolant spray (Pain Ease) with Amethocaine Gel (AnGel) to reduce the pain associated with intravenous(IV) cannulation in children.

Dr Benjamin D'Souza0 个研究点目标入组 280 人开始时间: 2009年9月15日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
280

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
6 Years 至 18 Years(—)
性别
All

入选标准

  • Children between 6 and 18 yrs of age, presenting to the pediatric emergency department(PED) and requiring IV cannulation

排除标准

  • Patients requiring urgent vascular access
  • Patients with impaired consciousness, a history of psychiatric illness or with developmental delay
  • Use of opioid analgesics or sedating agents within 4 hours of enrollment
  • Patients with pain score of greater than 6 (Pain Scale 0-10), i.e. requiring urgent analgesia
  • In patients with Diabetes Mellitus or patients with Cold hypersensitivity as Pain Ease is specifically contraindicated in these groups.
  • Sensitivity or previous adverse reactions to halogenated hydrocarbons or amethocaine
  • Non English speaking families
  • Those unable to understand the study protocol or the Visual Analog scale

研究者

发起方
Dr Benjamin D'Souza

相似试验